What is the recommended workup and treatment for sacroiliitis?

Sacroiliitis Workup and Treatment

For suspected sacroiliitis, start with plain radiographs of the sacroiliac joints as the first imaging study, followed by MRI if radiographs are negative or equivocal; for treatment, initiate NSAIDs immediately, and if inadequate response after 1 month, add a TNF inhibitor rather than continuing NSAIDs alone. 1, 2, 3

Diagnostic Workup

Initial Imaging Approach

Plain radiographs of the sacroiliac joints are the first-line imaging modality 1, 2. This recommendation comes from both the 2017 ACR Appropriateness Criteria and 2015 EULAR guidelines, which give radiography the highest rating (9/9) for initial evaluation. Complementary spine radiographs should also be obtained 1.

When Radiographs Are Negative or Equivocal

MRI of the sacroiliac joints without contrast is the next step when radiographs are negative or equivocal and clinical suspicion remains high 1, 2. The 2017 ACR guidelines rate MRI without contrast as 8/9 for this scenario. MRI with and without contrast is an equally appropriate alternative (also rated 8/9), with contrast potentially helpful for identifying inflammatory changes 1.

Key MRI findings to assess:

• Active inflammatory lesions: primarily bone marrow edema
• Structural lesions: erosions, new bone formation, sclerosis, and fat infiltration 2

Important caveat: MRI of the spine is not generally recommended for diagnosing axial spondyloarthropathy 2. Focus imaging on the sacroiliac joints.

Alternative Imaging

CT without contrast (rated 7/9) may identify subtle erosions in patients unable to undergo MRI 1, 2. However, avoid CT as first-line imaging—it provides less information about inflammation and delivers higher radiation exposure.

Do not use bone scintigraphy, ultrasound, or PET/CT for diagnosing sacroiliitis 1, 2. These modalities lack sufficient diagnostic accuracy.

Clinical Assessment

Look for these specific features:

• Age < 45 years at symptom onset
• Inflammatory back pain pattern: morning stiffness > 30 minutes, improvement with exercise, nocturnal pain in second half of night
• Buttock pain (often alternating)
• Duration > 3 months before considering inflammatory etiology 4, 5

Laboratory Testing

• HLA-B27 testing supports diagnosis but is not diagnostic alone 6
• Inflammatory markers (ESR, CRP) are elevated in ~90% of cases 5
• Blood cultures if infectious sacroiliitis suspected (positive in only 6.4% of cases) 7
• Consider biopsy or aspiration if infectious etiology suspected—confirms diagnosis in 28.6% and 14.3% respectively 7

Treatment Algorithm

Step 1: Initial Pharmacologic Management

NSAIDs are strongly recommended as first-line treatment over no treatment 8, 9, 8, 9, 4, 3. This is a strong recommendation despite very low quality evidence, based on established efficacy in adult spondyloarthritis.

• No specific NSAID is preferred over another 4, 3
• Continuous NSAID use (not on-demand) is recommended for active disease to control symptoms 4
• Define NSAID failure as inadequate response after 1 month of continuous use (at least two different NSAIDs for 15 days each) 4

Step 2: Escalation for Active Disease Despite NSAIDs

Adding a TNF inhibitor is strongly recommended over continuing NSAID monotherapy 8, 9, 8, 9, 3. This is based on low-quality pediatric evidence and high-quality adult data from randomized controlled trials.

Available TNF inhibitors: etanercept, adalimumab, infliximab, golimumab 8

Do NOT use methotrexate monotherapy for axial sacroiliitis—this is a strong recommendation against, based on adult data showing lack of effectiveness 8, 9, 4. Methotrexate may only have utility as adjunct therapy if concomitant peripheral polyarthritis exists or to prevent anti-drug antibodies against monoclonal TNF inhibitors 8.

Alternative for TNF Inhibitor Contraindications or Failure

Sulfasalazine is conditionally recommended only for patients with contraindications to TNF inhibitors or who have failed more than one TNF inhibitor 8, 9. This recommendation is conditional due to limited efficacy demonstrated in trials. Sulfasalazine has NO proven efficacy for purely axial disease 10, 4.

Step 3: Biologic Failure

For adults with ankylosing spondylitis:

• After first TNF inhibitor failure: Consider secukinumab or ixekizumab (IL-17 inhibitors) over switching to a second TNF inhibitor if primary non-response 3
• If secondary failure (good initial response then loss of efficacy): Switching to a different TNF inhibitor is conditionally recommended 3

Adjunctive Therapies

Glucocorticoids

Systemic glucocorticoids are strongly recommended AGAINST for long-term use 4, 3. The risks outweigh benefits for axial disease.

Local glucocorticoid injections are conditionally recommended in specific scenarios:

• Intra-articular sacroiliac joint injections for isolated active sacroiliitis despite NSAIDs 8, 10, 4, 3
• Should be performed in experienced centers, preferably with imaging guidance (ultrasound or CT) 4
• Reasonable dose: 40 mg methylprednisolone per sacroiliac joint 11

Bridging oral glucocorticoids (< 3 months) during initiation or escalation of therapy may be considered for high disease activity, limited mobility, or significant symptoms 8, 9, 8, 9. This is conditional due to known pediatric glucocorticoid risks.

Physical Therapy

Physical therapy is strongly recommended for patients with or at risk for functional limitations 8, 9, 3.

• Active interventions (supervised exercise) are preferred over passive modalities (massage, ultrasound, heat) 3
• Land-based therapy is conditionally recommended over aquatic therapy 3
• Focus on identifying and reducing mechanical factors contributing to microtrauma and repetitive stress 9

Special Considerations

Infectious Sacroiliitis

If infectious etiology suspected (fever, elevated inflammatory markers, risk factors):

• Imaging is essential: CT reveals erosions (84.6%) and periarticular involvement (69.2%); MRI detects soft tissue abscesses (30.8%) and extension to adjacent structures (38.5%) 7
• Antibiotics are the treatment of choice for pyogenic sacroiliitis 6
• Consider tuberculosis (34.3% of infectious cases) and brucellosis (20%) in appropriate clinical contexts 5, 7

Monitoring Stable Disease

For patients achieving disease control:

• On-demand NSAIDs are strongly recommended over continuous use once stable 3
• Do not routinely discontinue or taper biologics in stable patients—both are conditionally recommended against 3

Common Pitfalls to Avoid

1. Do not rely on MRI of the spine for diagnosing sacroiliitis—focus on sacroiliac joint imaging 2
2. Do not use methotrexate monotherapy for axial disease—it is ineffective 8, 4
3. Do not use systemic glucocorticoids long-term for axial disease 4, 3
4. Do not delay TNF inhibitor if NSAIDs fail after 1 month—earlier biologic therapy improves outcomes 4, 3
5. Avoid peritendinous injections of Achilles, patellar, and quadriceps tendons due to rupture risk 4, 3